Cargando…
Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel
AIM OF THE STUDY: Cervical cancer is the second most common malignancy in women worldwide. Everolimus displays direct effects on growth and proliferation of cancer cells via inhibition of mammalian target of rapamycin (mTOR) protein, which is known to be associated with drug resistance. In this stud...
Autores principales: | Yilmaz, Akin, Alp, Ebru, Onen, H. Ilke, Menevse, Sevda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829746/ https://www.ncbi.nlm.nih.gov/pubmed/27095936 http://dx.doi.org/10.5114/wo.2016.58498 |
Ejemplares similares
-
Effect of Gallic acid in potentiating chemotherapeutic effect of Paclitaxel in HeLa cervical cancer cells
por: Aborehab, Nora M., et al.
Publicado: (2019) -
HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma
por: Peng, Jinxia, et al.
Publicado: (2020) -
HDAC inhibitors, MS-275 and salermide, potentiates the anticancer effect of EF24 in human pancreatic cancer cells
por: Yar Saglam, Atiye Seda, et al.
Publicado: (2016) -
Study of Paclitaxel-Treated HeLa Cells by Differential Electrical Impedance Flow Cytometry
por: Kirkegaard, Julie, et al.
Publicado: (2014) -
Effect of API-1 and FR180204 on cell proliferation and apoptosis in human DLD-1 and LoVo colorectal cancer cells
por: Saglam, Atiye Seda Yar, et al.
Publicado: (2016)